bisacodyl has been researched along with Kidney Failure, Chronic in 1 studies
Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
"Bisacodyl treatment had no effect on plasma K+ concentrations in control subjects, but significantly decreased the mean interdialytic plasma K+ concentration (from 5." | 1.32 | Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease. ( Mathialahan, T; Sandle, GI, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mathialahan, T | 1 |
Sandle, GI | 1 |
1 other study available for bisacodyl and Kidney Failure, Chronic
Article | Year |
---|---|
Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease.
Topics: Adult; Aged; Bisacodyl; Case-Control Studies; Cathartics; Colon; Fasting; Female; Gastrointestinal A | 2003 |